Crossmark

Recent progress in mitochondria-targeting-based nanotechnology for cancer treatment

Crossref DOI link: https://doi.org/10.1039/D1NR01068A

Published Online: 2021

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Qin, Jingbo

Gong, Ningqiang

Liao, Zhihuan

Zhang, Shouwen

Timashev, Peter https://orcid.org/0000-0001-7773-2435
Huo, Shuaidong https://orcid.org/0000-0003-3590-044X
Liang, Xing-Jie https://orcid.org/0000-0002-4793-1705
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82001959, 31630027, 32030060)

Deutsche Forschungsgemeinschaft (31761133013)

National Key Research and Development Program of China (2018YFE0117800)

Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety (NSKF202003)

Xiamen University (20720200036)
License Information

Accepted Manuscript valid from 2022-04-03
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

IDENTIFIERS

: Peter Timashev (ORCID)

: Peter Timashev (ResearcherID)

: Shuaidong Huo (ORCID)

: Shuaidong Huo (ResearcherID)

: Xing-Jie Liang (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 17 February 2021; Accepted 3 April 2021; Accepted Manuscript published 3 April 2021; Advance Article published 12 April 2021; Version of Record published 23 April 2021